Polypharmacy in elderly cancer patients: Challenges and the way clinical pharmacists can contribute in resource‐limited settings
Open Access
- 14 February 2019
- journal article
- review article
- Published by Wiley in Aging Medicine
- Vol. 2 (1) , 42-49
Abstract
The aim of this study was to address the problems associated with polypharmacy in elderly cancer patients and to highlight the role of pharmacists in such cases in resource‐limited settings. A narrative review of existing literature was performed to summarize the evidence regarding the impact of polypharmacy in elderly cancer patients and the pharmaceutical strategies to manage it. This review emphasizes the significance of polypharmacy, which is often ignored in real clinical practice. Polypharmacy in the elderly cancer population is mainly due to: chemotherapy with one or more neoplastic agents for cancer treatment, treatment for adverse drug reactions due to neoplastic agents, the patient's comorbid conditions, or drug interactions. The role of the clinical pharmacist in specialized oncology hospitals or oncology departments of tertiary care hospitals is well established; however, this is not the case in many developing countries. A clinical pharmacist can contribute to solving the problems associated with polypharmacy by identifying the risks associated with polypharmacy and its management in resource‐limited settings. As in many developed countries, the involvement of a clinical pharmacist in cancer care for elderly patients may play a vital role in the recognition and management of polypharmacy‐related problems. Further research can be conducted to support this role.Keywords
This publication has 67 references indexed in Scilit:
- Impact and Feasibility of a Comprehensive Geriatric Assessment in the Oncology SettingAmerican Journal of Clinical Oncology, 2012
- Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortalityBritish Journal of Cancer, 2012
- Comprehensive Geriatric Assessment in the Decision-Making Process in Elderly Patients With Cancer: ELCAPA StudyJournal of Clinical Oncology, 2011
- Potential drug interactions in elderly cancer patientsCritical Reviews in Oncology/Hematology, 2011
- Adverse drug events in the outpatient setting: an 11‐year national analysisPharmacoepidemiology and Drug Safety, 2010
- Potentially severe drug interactions in elderly outpatients: results of an observational study of an administrative prescription databaseJournal of Clinical Pharmacy and Therapeutics, 2009
- Medication errors: the importance of an accurate drug historyBritish Journal of Clinical Pharmacology, 2009
- Polypharmacy in elderly patientsThe American Journal of Geriatric Pharmacotherapy, 2007
- Hospitalisations and emergency department visits due to drug–drug interactions: a literature reviewPharmacoepidemiology and Drug Safety, 2006
- Potentially Inappropriate Medication Use Among Elderly Home Care Patients in EuropeJAMA, 2005